Neurology

Undesired weight changes and rising alcohol intake are a few issues facing adults due to prolonged pandemic-related stress, the latest American Psychological Association Stress in America™ poll reveals.

Director of the National Institute on Alcohol Abuse and Alcoholism George F Koob, PhD, talked with Patient Care Online about dangerous alcohol consumption linked to pandemic-related stress.

Developed by researchers from the University of Pennsylvania Health System, the model uses a referral management system to support primary care patients with mental health needs.

Healthcare providers are advised to weigh carefully the risks vs benefits of continuing lamotrigine therapy and not to substitute with another drug from the class.

Brain fog topped the list of neurological symptoms in patients with long-haul COVID-19 whose illness was not severe enough to warrant hospitalization, according to a novel study.

Headache specialist Peter McAllister, MD, discusses how the new migraine medications differ from existing therapies.

Preliminary findings being presented at the International Stroke Conference 2021 show some of the same risk factors associated with stroke in older adults also cause stroke in younger adults.

International Stroke Conference 2021: A new analysis of the landmark REDUCE-IT trial found that adding icosapent ethyl to treatment regimens that already include statins further reduces stroke risk.

Study: Anosmia, myalgias, and headache were the most common extrapulmonary symptoms seen in COVID-19 patients at first presentation, say investigators.

International Stroke Conference: Adults with dementia are more likely to be infected with COVID-19, but no more likely to die from it vs those without cognitive impairment.

Stroke patients are nearly 50% more likely vs heart attack patients to develop depression, according to new research being presented at the upcoming International Stroke Conference.

Gradually worsening weakness in the shoulders, neck, and face of 4-5 days' duration is the presenting complaint of a man in his 60s. ED physician Brady Pregerson, MD, asks, "What's your diagnosis?"

The latest Stress in America™ poll from the American Psychological Association shows many US adults have suffered negative mental and physical changes due to pandemic-related stress.

New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next.

A recent survey queried cluster headache patients to compare cluster headache pain intensity to other painful disorders. The results, highlighted in this quick slideshow, may surprise.

In a new survey of patients with severe asthma, COVID-19-related anxiety was found to be a potential risk factor for clinical worsening of disease and decline in quality of life.

Irregular sleeping patterns can increase risk of depression and lower daily mood over the long term, according to a new study of first-year medical students.

Authors of 2 large cannabis-user database analyses discuss the possible reasons for observed dose increase over time by individuals using inhaled cannabis for pain relief.

In animal models, pain relief from cannabis has been found to be greater in females; new research on pain relief from inhaled cannabis in regular users found something different.

Research on pain relief from use of medical cannabis poses myriad challenges. Veteran researchers discuss 2 new studies based on a deep well of user data.

Obesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.

Heart disease, again the leading cause of death worldwide, may remain so for many years as a result of COVID-19 pandemic conditions, says AHA Update Writing Committee Chair.

Antidepressants, although guideline-recommended and widely prescribed for common pain conditions, may not be as effective as perceived. Author of a new meta-analysis explains.

Acupuncture, massage, meditation—what does the latest research say about these and other popular alternative therapies for pain management?

Migraine headaches are a condition commonly seen in primary care. Here is a top-line look at the evidence for efficacy of the wide range of treatments available.

In a phase 2/3 study, nearly half of rimegepant-treated patients demonstrated ≥50% reduction in the number of moderate-to-severe migraine days per month

The COVID-19 pandemic, says Dr Michael Myers, is an unprecedented environment for practicing medicine and for practitioners to effectively process daily experience.

Michael Myers, MD, a physician to physicians, urges any clinician who, worn out by COVID-19, has thoughts of leaving medicine to seek counseling first.

Thirty-day hospital readmission was found to be higher among cardiovascular patients who believed readmission was highly likely vs those who did not believe so.

Are you caught up on the latest guidance for the nonpharmacologic and pharmacologic treatment of major depressive disorder? Find out with this quick quiz.